Table 2.
Follow-up and outcomes
| Follow-up and Outcomes | Black Participants with Membranous Nephropathy (n=118) | Participants with Membranous Nephropathy that Were Not Black | |
|---|---|---|---|
| Two APOL1 Risk Alleles | Zero/One APOL1 Risk Alleles | ||
| (n=16) | (n=102) | (n=572) | |
| Follow-up months, median (IQR) | 42 (27–121) | 51 (29–79) | 52 (32–79) |
| eGFR measurements per person, median (IQR)a | 10 (6–21) | 10 (5–22) | 9 (5–15) |
| Kidney failure, n (%) | 5 (31) | 11 (11) | 31 (5) |
APOL1, apolipoprotein L1; IQR, interquartile range.
a
Missing data: Two APOL1 risk alleles n=1, zero/one APOL1 risk alleles n=1, not Black n=125.